Duke Street Bio
PrivateLast Round
Seed Round
May 15, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Duke Street Bio operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a VC Round in May 2022.
Duke Street Bio is a biotechnology company that develops precision medicine-based cancer therapies targeting DNA damage repair deficiencies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Duke Street Bio Comparables
Compare Duke Street Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synnovation Therapeutics | 89% | |
| Tilikum Therapeutics | 86% | |
| Idience Co., Ltd. | 84% |
For institutional investors. Book with your work email.
Duke Street Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 15, 2026 | ||||
| Seed Round | Jan 3, 2024 | ||||
| VC Round | May 22, 2022 | ||||
| Seed | May 24, 2021 | ||||
| Seed | Sep 3, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 40% MoM, reaching 1.3K.
- May 15, 2026
Raised $4.1M in a seed funding round.
For institutional investors. Book with your work email.
Duke Street Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Duke Street Bio's valuation, stock price, and market status.
Is Duke Street Bio a public or private company?
Duke Street Bio is a private company.
What is the current stock price of Duke Street Bio?
Duke Street Bio is a private company, so its shares have no public market price. Caplight tracks Duke Street Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Duke Street Bio worth (valuation)?
Valuation information for Duke Street Bio is not publicly available.
Can I buy Duke Street Bio stock?
Duke Street Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Duke Street Bio's last funding round?
Duke Street Bio's most recent funding round was Seed Round on May 15, 2026.
Who are the main investors in Duke Street Bio?
Investor information for Duke Street Bio is not publicly disclosed.
Will Duke Street Bio IPO soon?
No public IPO plans have been announced for Duke Street Bio.
How can I track Duke Street Bio secondary market activity?
Caplight tracks bids, offers, and trades in Duke Street Bio's shares on secondary markets.